Text Size

Systemic expression of Alu RNA in patients with geographic atrophy secondary to age-related macular degeneration

Yoshida H., Matsushita T., Kimura E., Fujita Y., Keany R., Ikeda T., Toshimori M., Imanaka T., Nakamura M.

  • 2019
  • PLoS ONE
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology


  • Affiliations

    Research and Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan; Research and Development Division, Santen Inc., Emeryville, CA, United States

Related Publications

Aging-associated changes of optical coherence tomography-measured ganglion cell-related retinal layer thickness and visual sensitivity in normal Japanese

Iwase A., Higashide T., Fujii M., Ohno Y., Tanaka Y., Kikawa T., Araie M.

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022